Form 4: Cardinal Health Director Receives RSU Grant

Cardinal Health Inc. director Akhil Johri was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Akhil Johri, a Director of Cardinal Health Inc. (CAH), received a grant of 1,067 restricted share units (RSUs).
• The transaction occurred on November 5, 2025.
• These RSUs were granted at a price of $0, indicating they are part of a compensation package.
• Following this transaction, Mr. Johri beneficially owns 22,868 common shares.
• The RSUs are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• A Limited Power of Attorney was filed, authorizing specific individuals to handle SEC reporting on behalf of Akhil Johri.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is a positive event, aligning management interests with shareholders, but it is a routine compensation matter and not a significant operational or financial announcement.

Positives

• The grant of 1,067 restricted share units aligns the director's interests with long-term shareholder value.
• The transaction increases the director's beneficial ownership in the company, demonstrating continued commitment.

Negatives

• No specific negatives are identified in this routine Form 4 filing.

Risks

• The value of the restricted share units is subject to the future performance of Cardinal Health Inc.'s stock price until vesting.
• The vesting of the RSUs is contingent on continued service as a director until the vesting date.

Future Outlook

The restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs prior to that date, indicating a future milestone for the director's compensation.

Industry Context

This is a routine director compensation event and does not provide specific insights into broader industry trends or competitive landscape. Such grants are common practice for retaining and incentivizing board members in publicly traded companies across various industries.

Comparison to Industry Standards

• The grant of restricted share units to a director is a standard practice for executive and board compensation in publicly traded companies, aligning director interests with long-term shareholder value.
• Many companies, including peers in the healthcare distribution sector, utilize similar equity-based compensation structures to incentivize leadership. Specific comparable companies or projects are not detailed in this filing.

Corporate Governance

Related Party Transactions

• The grant of restricted share units to Akhil Johri, a director of Cardinal Health Inc., constitutes a transaction with a related party.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value, potentially fostering better governance and strategic decisions.
• Management: The Power of Attorney streamlines SEC reporting for the director, reducing administrative burden.

Next Steps

• The restricted share units will vest on November 5, 2026, or potentially earlier if the 2026 Annual Meeting of Shareholders precedes that date.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted share units to a director, which is a standard compensation practice. While it aligns the director's interests with shareholders, it does not provide new material information that would significantly alter the investment thesis for Cardinal Health Inc. Therefore, a 'hold' recommendation is appropriate as this filing alone does not warrant a change in investment position.

Keywords

Cardinal Health, CAH, Akhil Johri, Form 4, Restricted Share Units, RSU Grant, Director Compensation, Beneficial Ownership, SEC Filing